Ocular Side Effects of Antibody-Drug Conjugates
Oct 06, 2023•29 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Antibody-drug conjugates (ADCs) are new chemotherapeutic agents that can cause significant ocular side effects. Drs. Meghan Berkenstock, Lauren Dalvin, and Stella Kim review this new class of drugs and how they can affect the eye, providing essential tips for what to look for, when to screen, and how to treat the side effects.
Prescribing information mentioned in this episode:
Elahere (mirvetuximab soravtansine-gynx)
Tivdak (tisotumab vedotin-tftv)
For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
For the best experience, listen in Metacast app for iOS or Android